Upregulation of PD-L1 in tumor cells and in the tumor microenvironment by radiotherapy is a complex mechanism and thought to be through four pathways: Interferon γ signaling, epidermal growth factor receptor pathway, DNA damage signaling pathway, and cGAS-STING pathway (77). Here, CGAS is linked to neoplasm.